Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls-Reference-Cited by-同舟云学术

Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls

Published:2019-11 Issue:49 Volume:37 Page:7280-7288
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Pasmans Hella,Schurink-van't Klooster Tessa M.,Bogaard Marjan J.M.,van Rooijen Debbie M.,de Melker Hester E.,Welters Marij J.P.,van der Burg Sjoerd H.,van der Klis Fiona R.M.,Buisman Anne-Marie

Funder

Ministry of Health, Welfare and Sports

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference40 articles.

1. Papillomaviruses in the causation of human cancers – a brief historical account;zur Hausen;Virology,2009

2. Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases;Garland;N Engl J Med,2007

3. Four year efficacy of prophylactic human papillomavirus quadrivalent vaccine against low grade cervical, vulvar, and vaginal intraepithelial neoplasia and anogenital warts: randomised controlled trial;Group FIIS;BMJ,2010

4. Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions;Group FIS;N Engl J Med,2007

5. Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial;Paavonen;Lancet,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevalence and risk factors for HPV seropositivity and anogenital DNA positivity among men who have sex with men: a repeated cross-sectional study;International Journal of Infectious Diseases;2024-08

2. Immunogenicity and Safety of Extended-Interval 2-Dose Regimens of 9vHPV Vaccine;Pediatrics;2024-07-09

3. The clinical effectiveness of one-dose vaccination with an HPV vaccine: A meta-analysis of 902,368 vaccinated women;PLOS ONE;2024-01-05

4. Durability of Immunogenicity at 5 Years after a Single Dose of HPV Vaccine Compared with 2 Doses in Tanzanian Girls Aged 9-14 Years:  Results of the Long-Term Extension of the DoRIS Randomised Trial;2024

5. The Clinical Effectiveness of One-Dose HPV Vaccine: A meta-analysis of 902,368 vaccinated women;2023-08-23